AbbVie Announces Significant Dividend Increase for Shareholders
AbbVie’s Quarterly Dividend Declaration
The board of directors of AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.55 per share. This decision underlines the company's commitment to delivering shareholder value through consistent and robust dividend payouts.
Dividend Details and Schedule
The declared dividend is set to be distributed on November 15, 2024, to stockholders who are on record as of the end of business on October 15, 2024. This schedule ensures that shareholders receive their due dividends in a timely manner.
Impressive Dividend Growth
Since AbbVie’s formation in 2013, the company has impressively increased its dividend by over 285 percent. This remarkable growth places AbbVie among the elite companies on the S&P Dividend Aristocrats Index, which highlights organizations that have consistently raised dividends for at least 25 years. This track record speaks volumes about the company’s financial health and its commitment to rewarding shareholders.
About AbbVie: Innovation and Commitment
AbbVie is dedicated to discovering and providing innovative medications and solutions aimed at addressing serious health issues both today and in the future. The company focuses on making a significant difference in the lives of individuals through various therapeutic areas, including immunology, oncology, neuroscience, and eye care. Their product offering includes an extensive range in the Allergan Aesthetics portfolio, further underscoring their commitment to advancing healthcare.
Connecting with AbbVie
For those interested in learning more about AbbVie’s mission and initiatives, additional information is accessible on their official website. You can also find them on various social media platforms like LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube, where they frequently update their community on new developments and offerings.
Frequently Asked Questions
What is the declared quarterly dividend amount by AbbVie?
The recent quarterly dividend declared by AbbVie is $1.55 per share.
When is the dividend payment date?
AbbVie plans to distribute the declared dividend on November 15, 2024.
What is AbbVie’s history with dividend increases?
Since its inception in 2013, AbbVie has increased its dividend by over 285 percent.
What index is AbbVie a part of due to its dividend performance?
AbbVie is a member of the S&P Dividend Aristocrats Index, which includes companies with a history of raising dividends for at least 25 consecutive years.
How can I connect with AbbVie for more information?
To get more information, you can visit AbbVie’s official website or follow them on social media platforms like LinkedIn and Facebook.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.